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Abstract
Cardiovascular magnetic resonance (CMR) has become a valuable investigative tool in many areas of cardiac
medicine. Its value in heart valve disease is less well appreciated however, particularly as echocardiography is a
powerful and widely available technique in valve disease. This review highlights the added value that CMR can
bring in valve disease, complementing echocardiography in many areas, but it has also become the first-line
investigation in some, such as pulmonary valve disease and assessing the right ventricle. CMR has many
advantages, including the ability to image in any plane, which allows full visualisation of valves and their inflow/
outflow tracts, direct measurement of valve area (particularly for stenotic valves), and characterisation of the
associated great vessel anatomy (e.g. the aortic root and arch in aortic valve disease). A particular strength is the
ability to quantify flow, which allows accurate measurement of regurgitation, cardiac shunt volumes/ratios and
differential flow volumes (e.g. left and right pulmonary arteries). Quantification of ventricular volumes and mass is
vital for determining the impact of valve disease on the heart, and CMR is the ‘Gold standard’ for this. Limitations
of the technique include partial volume effects due to image slice thickness, and a low ability to identify small,
highly mobile objects (such as vegetations) due to the need to acquire images over several cardiac cycles. The
review examines the advantages and disadvantages of each imaging aspect in detail, and considers how CMR can
be used optimally for each valve lesion.
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Review
Cardiovascular magnetic resonance (CMR) has unique
capabilities which can greatly benefit the assessment of
the patient with cardiac valve disease. While echocardio-
graphy (echo) remains the major imaging modality for
assessing valve disease, there are many areas where
CMR provides ‘added value’ to existing assessment and
can complement the echo assessment. CMR can also
p r o v i d eac o m p r e h e n s i v e‘stand-alone’ assessment in
some situations, delivering optimal assessment of
patients using a combination of several techniques.
These include quantifying the severity of the valve
lesion, determining aetiology, examining the conse-
quences for the relevant ventricle, and assessment of the
surrounding anatomy (e.g. aortic root). Additional infor-
mation on great vessel anatomy and the presence of
myocardial scar (infarction) can also be clinically useful.
The modality is used best by harnessing the advantages
it brings, rather than attempting to replicate echocardio-
graphy or x-ray computed tomography (CT). This
review will highlight the optimal use of CMR in valve
disease, highlighting the strengths of the technique and
also the potential pitfalls when assessing patients with
valve disease.
The advantages of CMR in valve disease
Valvular function & anatomy with unlimited imaging
planes
Most morphological and functional information is
obtained using cine CMR sequences, particularly steady
state free-precession (SSFP) sequences with their high
contrast between blood pool and surrounding structures
(Figure 1). These have largely replaced spoiled gradient
echo sequences, though the latter remain useful on
occasions for visualising the extent of flow disturbance
in selected cases. The ability to image in any plane
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inflow/outflow tracts, irrespective of thoracic anatomy
or difficult cardiac anatomy. This is particularly useful
for right-sided valves which can be challenging to visua-
lise with echo, particularly the pulmonary valve. An
additional advantage is that it facilitates direct measure-
ment of valve orifice area for stenosed valves by plani-
metry rather than calculation [1], and the same
technique can occasionally be used for the assessment
of regurgitant orifices if required. The anatomical infor-
mation from CMR cine images can be at least as good
as transoesophageal echocardiography, and valvar anat-
omy and function can often be visualised well with cine
images, along with the mechanism of regurgitation, par-
ticularly with thin (4-5 mm) slices. There are however
several limitations of CMR cine assessment, including a
relatively thick imaging slice (typically 5-8 mm) resulting
in partial volume effects, and the need to acquire cine
images over several cardiac cycles which results in sub-
optimal visualisation of small or more chaotically mobile
objects such as vegetations. The thin nature of cardiac
valves (typically 1-2 mm) makes them particularly prone
t op a r t i a lv o l u m ee f f e c t sd u et ot h es l i c et h i c k n e s so f
CMR images. Care is therefore required in placing
image slices perpendicular to the valve plane to mini-
mise these effects and in minimising slice thickness to
4-5 mm, but some aspects of finer valve anatomy may
be too difficult to visualise well with CMR. Furthermore,
for accurate assessment of the stenotic/regurgitant ori-
fice, positioning the image slice precisely at the valve
tips is important and misalignment may result in signifi-
cant error. Multiple parallel thin image slices in the
plane of interest can help to locate the one slice at the
optimal position of the valve tips.
The visual assessment of turbulent flow in stenotic or
regurgitant flow jets is also feasible with the cine
sequences described above, through visualisation of sig-
nal voids due to spin dephasing in moving protons [2].
Flow related signal loss seen on SSFP images occurs
where voxels span a range of velocities, notably in the
shear layers that can surround the more coherent jet
core. The location and direction of regurgitant or steno-
tic jets can be assessed (Figure 2), which can provide
valuable information about the valve lesion. In
Figure 1 SSFP sequence in the LV outflow tract view in systole showing restricted aortic valve leaflets (black arrows) and a high
velocity jet of aortic stenosis (white arrow), with high signal (white) from the more stable core surrounded by low signal (black) due
to shear and turbulence. Parallel dashed lines indicate the slice position for imaging the valve tips for assessment of valve area (Figure 6).
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vena contracta provide useful information, with milder
leaks having narrower jets in general. Lastly, the cine-
visualised flow jets can also assist in planning the place-
ment of subsequent velocity-encoded images. Signal
voids seen on SSFP imaging are however substantially
related to the acceleration of blood rather than the velo-
city alone, and may underestimate the degree of flow
disturbance when assessing the degree of regurgitation.
Narrow (mild) jets may be difficult to visualise due to
the lack of shear layers at the edge of the jet. Gradient
echo sequences are more sensitive than SSFP sequences
for evaluating the presence and magnitude of turbulent
jets [3], and this sensitivity is increased with lengthening
echo time [4,5]. Assessing the severity of regurgitation
with visual assessment of cine images requires care and
caution however, as the technique is subject to slice
positioning, partial volume effects, the insensitivity of
SSFP sequences, and to other sequence parameters. This
method can provide an approximate guide to the degree
of regurgitation, and distinguishing mild and severe
regurgitation is feasible, but finer differentiation of
severity is rarely possible.
Accurate and reproducible ventricular volumes, function
and mass
Accurate measurement of left and right ventricular
volumes, function and mass are vital for assessing the
impact of valve lesions on the ventricles. Excessive dila-
tion or reduced ventricular function are strong indica-
tors of a poor prognosis [6], and reliable measurement
is important. CMR is the most accurate and reproduci-
ble technique for assessing both left and right ventricu-
lar volumes & mass [7-9], and newer steady-state free-
precession sequences appear to be even more accurate
than older gradient echo cine sequences [10,11]. RV
volumes are particularly useful as these are difficult to
achieve by other methods, though accurate measure-
ment is more difficult than for LV volumes. The role of
left ventricular (LV) mass in valve disease has not been
studied as extensively as volume, possibly due to the
inaccuracies of measurement by M-mode or 2-dimen-
sional echo [12], and LV mass may become a useful
measure in the future, particularly for patients with aor-
tic stenosis. Reproducibility is important for serial
assessment of ventricular size, as patients with valve
lesions are often monitored for many years if
Figure 2 LVOT view in diastole showing jet of eccentric aortic regurgitation (arrow) visualised by the low signal on SSFP sequences,
due to spin-dephasing caused by shear and turbulence.
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rioration occur. CMR is highly reproducible [13], and
being a 3-dimensional technique, is more sensitive to
changes than one or two-dimensional LV diameters
[12]. CMR is also less prone than echocardiographic dia-
meters to variations in measurement position, which can
occur, despite standard guidelines [14]. The accuracy of
CMR is, however, dependent on correct placement of
the basal ventricular image slice, and careful contour
placement during post-processing is crucial, with correct
differentiation of atrial and ventricular chambers, espe-
cially for the right ventricle. Significant error can occur
if the basal slice is incorrectly included/excluded from
ventricular volumes. Post-processing software that
includes long axis visualisation of the valves to ensure
appropriate slice inclusion significantly aids accuracy.
CMR-derived ventricular stroke volumes can also be
used to quantify mitral and tricuspid regurgitation,
either in conjunction with flow measurement or with
volume data alone if the valve regurgitation is isolated
[15] - see below, but the issues about accuracy of con-
tour placement still apply.
Flow and velocity quantification
The ability to quantify flow directly using through-plane
phase contrast velocity mapping [16] is a unique advan-
tage of CMR, and does not rely on calculation from
complex equations, as echo or invasive catheterisation
techniques require. The technique exploits the property
of protons moving in a magnetic field gradient, in which
they acquire a shift in the phase of their rotational spin
as compared with stationary protons, and the magnitude
of this phase shift is proportional to their velocity. By
producing images from the phase information, velocity
can be measured [17], and is visually displayed in grey-
scale images (Figure 3a). Flow is derived from through-
plane velocity maps by integrating the velocity of each
pixel and its area over time, typically a single cardiac
cycle (Figure 3b). CMR flow measurement shows good
accuracy in in-vitro studies and it correlates well with
invasive in-vivo measurements [18-22]. In vivo studies
are hampered by the lack of a true ‘gold standard’ tech-
nique for comparison - invasive measures of flow rely
on complex calculations and assumptions which may
not hold true. The temporal resolution of CMR flow
measurement is typically 25-45 msec, which is lower
than for continuous wave Doppler velocity measure-
ments in echo, but is good enough for most flow and
velocity measurements. Flow measurement is however
critically dependent on a homogenous magnetic field,
and ensuring the image slice is at the magnet isocentre
is important for minimising error. Despite this, phase
offset errors due to eddy currents in the magnetic field
can still occur, affecting background flow measurements.
These are likely to be worse with newer breath-hold
sequences due in part to faster gradient switching, and
Figure 3 Through-plane phase contrast velocity mapping for flow quantification of aortic regurgitation at the valve tips.L e f t :
magnitude (anatomical) images in systole (top) and diastole (bottom). Right: corresponding phase (velocity) images at the same phase; forward
flow in white, regurgitant flow in black; dotted line represents region of interest for post-processing of velocity data. Resulting flow-time graph
after integration of velocity in each voxel over one cardiac cycle, demonstrating forward flow above the line and regurgitant flow
below the line. The area under the curve represents the volume of flow, and can be calculated by the software.
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non-breath-hold sequences [23,24]. Background flow
correction using phantoms can correct the majority of
the error [23,24], and is important for accuracy [25].
The majority of the validation work has been carried
out using older non-breath-hold flow sequences, and
these are recommended for accurate flow measurement
due to the lower background offset error and better vali-
dation, particularly if phantom correction is not used.
The background offset errors are also worse in very
oblique imaging planes [25], and using imaging planes
closer to the transverse body plane is helpful [25], where
feasible.
Velocities can also be assessed with either ‘through-
plane’ velocity mapping (as used for flow above) or ‘in-
plane’ phase contrast sequences, measuring velocity
within the plane of the slice (Figure 4). The in-plane
sequences can demonstrate the origin and direction of a
jet, and can be useful for visualising the site of stenosis
and measuring velocity along the course of a jet, or can
assist in planning the subsequent perpendicular or
‘through-plane’ slice. In-plane sequences may be less
accurate however for measuring velocity in a stenotic
lesion, particularly peak velocity, for a number of rea-
sons. Due to the image slice thickness (typically 5-7 mm
relative to a stenotic jet width of 2-4 mm), they are sub-
ject to partial volume effects, in which several velocities
occur within a single voxel and an averaged phase shift
is measured [26]. The temporal resolution, while reason-
able (typically 20-25 msec), is low when compared to
fast-changing jet velocities (by comparison, continuous
wave Doppler echo temporal resolution can be ~2
msec), and the true peak velocity may be missed. Lastly,
the accuracy of CMR velocity measurement in high
velocity jets is reduced, particularly with velocities above
3.5-4 m/sec [21,22]. This is due to signal loss from tur-
bulence [26], and phase shift errors due to fast accelera-
tion and intravoxel dephasing. Utilising sequences with
av e r ys h o r t‘echo-time’ (~2 msec) can reduce these
errors [22] and future applications may use these ‘ultra-
short’ echo time sequences. Narrow, high velocity flow
jets (e.g. severe aortic stenosis) are thus especially
Figure 4 Example of in-plane phase contrast velocity mapping in the LV outflow tract in a patient with dynamic outflow tract
obstruction. Left: cine image; right: corresponding phase image from in-plane velocity mapping. The highest velocities can be visualised in the
outflow tract (arrowed), below the aortic valve. LV = left ventricle; Ao = aorta.
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narrow and turbulent for accurate velocity measure-
ment. Through-plane velocity mapping sequences may
reduce some of the errors, particularly partial volume
effects, as they take advantage of the better within-plane
image resolution (typically ~1 mm), to cope with narrow
jets. They are thus the preferred method for accurate
velocity measurement, though the acceleration & turbu-
lence errors still apply and the temporal resolution is
similar. The highest velocity narrow jets may still be too
difficult to measure however. Through-plane velocity
measurement relies on the plane being placed at the site
of maximal velocity (if peak velocity is desired), which is
why in-plane velocity mapping to guide placement of
the through-plane image can be helpful, unless the site
of maximal velocity is predictable. Fortunately, back-
ground phase offset errors only result in a small change
in the velocity of individual voxels (as opposed to mod-
erate differences when summed for flow quantification),
so do not substantially affect velocity measurement.
In addition to flow quantification, recently developed
3-dimensional in-plane CMR flow sequences can mea-
sure velocities in 3 dimensions simultaneously [27,28],
allowing the visualisation of complex flow patterns.
Future work may examine the utility of this technique
for valve lesions and other areas of clinical utility.
Left-sided valve lesions
Aortic stenosis
The assessment of aortic stenosis is enhanced with CMR
through accurate assessment of the anatomy of the valve
and aortic root, quantification of LV mass and function
to indicate the precise effect on the LV, and measure-
ment of the velocity of the stenotic jet where this is dif-
ficult with echo. The excellent visualisation of anatomy
provided by CMR allows accurate evaluation of the
severity of aortic stenosis [29], usually starting with
standard and ‘coronal’ LV outflow tract views (Figure 5),
from which a good qualitative assessment of the valve
can be made. Direct planimetry of the aortic valve ori-
fice is the most useful technique for quantifying stenosis
severity, achieved by placing an imaging plane through
the valve tips in systole (Figure 6). It is important how-
ever to ensure the image slice is thin (4-5 mm) and pre-
cisely at the valve tips, and acquiring multiple parallel
thin slices parallel to the valve orifice may aid in identi-
fying the true orifice [30]. This technique agrees well
withmeasured aortic valve area on transoesophageal
echocardiography [30-32] and also with estimated valve
area from the continuity equation [31,32]. Trans-valvar
velocity can be measured withvelocity mapping [33,34],
though peak velocity may be less accurate (often under-
estimated) compared to continuous wave Doppler echo,
due to the small width of very high velocity jets (partial
volume effects), lower temporal resolution, and artefacts
from turbulent jets, as indicated earlier. For these rea-
sons, direct planimetry of the valve orifice area may be a
more reliable assessment of aortic stenosis with CMR. It
has been suggested that the continuity equation could
be used with CMR to estimate valve area [35], with
direct measurement of the LVOT area being an advan-
tage over echo. However, this is unnecessary when CMR
can directly measure the valve area itself, and the conti-
nuity equation relies on multiple measurements and an
equation to calculate (rather than directly measure) the
valve area, all of which increase the potential for error.
Despite the limitations, CMR measurement of velocity
is advantageous in angulated roots where correct echo
beam alignment with the stenotic jet is difficult. In addi-
tion, many stenotic jets are not parallel to the LV out-
flow tract, and are also inaccurately assessed with echo,
even when outflow tract visualisation is good. In-plane
velocity mapping in the outflow tract is useful to iden-
tify the location of maximal velocity - this is usually just
distal to the valve tips in valvar stenosis. This can be fol-
lowed with through plane velocity mapping in a plane
perpendicular to the direction of flow, positioned at the
identified location of maximal velocity (Figure 1). This
combination reduces partial volume effects while ensur-
ing the peak velocity is measured, and mean velocity
can also be assessed from the through-plane velocity
measurements. Ensuring the correct slice position for
flow measurement is important for accuracy; and
although this image appears similar to that through the
valve tips, the position of maximal velocity (the vena
contracta) usually lies a few millimetres distal to the
v a l v et i p s ,s ot h ei m a g e sm a yn o tb ei ni d e n t i c a l
locations.
Other advantages in aortic stenosis include the ability
to differentiate sub-valvar and supra-valvar stenosis,
which are easily visualised with CMR cine imaging, and
the site of velocity acceleration can be accurately located
with in-plane velocity mapping. CMR can also accu-
rately assess the ascending aorta, which may be dilated,
particularly with bicuspid aortic valves, and may alter
surgical management either at the time of valve replace-
ment or by indicating that root ± valve replacement are
required due to excess aortic dilation.
Highly accurate LV mass measurement provides a
more precise and sensitive measure of the effect of aor-
tic stenosis on the left ventricle than measuring myocar-
dial wall thickness. LV mass has been a poorly
examined parameter in aortic stenosis, likely due to the
inaccuracies of echocardiographic M-mode measure-
m e n t ,a n dC M R - d e r i v e dL Vm a s sm a yp r o v et ob ea
useful tool but needs further examination. Late gadoli-
nium enhancement imaging in patients with aortic ste-
nosis has shown patchy mid-wall enhancement in up to
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junction with significant LV hypertrophy, and often in
the basal lateral wall [36]. This likely reflects focal areas
of fibrosis, which have also been shown in autopsy stu-
dies [37]. Early reports have shown that this is asso-
ciated with a worse prognosis [38]. Future CMR
techniques may include the assessment of diffuse
fibrosis using T1 mapping and other CMR techniques,
and this is likely to be an exciting area of development.
Aortic regurgitation
The advantages of CMR in aortic regurgitation are
quantitation of the regurgitation and of LV volumes and
function, particularly for serial measurement. Aortic
Figure 5 Aortic stenosis in a bicuspid aortic valve: standard left ventricular outflow tract (LVOT) view (top) and ‘coronal’ LVOT view
(bottom), acquired perpendicular to the standard LVOT view through the valve tips. Note the domed leaflets with restricted tips typical
for congenital stenosis (white arrows) and the high velocity jet (black arrows).
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phy, which mostly relies on qualitative and semi-quanti-
tative measures of severity. CMR can accurately quantify
the amount of regurgitation using flow mapping, and
derived values such as regurgitant fraction (regurgitant
volume/forward volume × 100%) can be obtained. Ima-
ging the valve occurs in much the same way as for aor-
tic stenosis, using long axis LVOT views (Figure 7),
from which qualitative visualisation of the regurgitation
can be performed (Figure 2). Flow can be measured by
placing the imaging slice for flow mapping just above
the aortic valve, quantifying both forward and regurgi-
tant flow per cardiac cycle [20,39,40] (Figure 3). Posi-
tioning the imaging slice just above the valve (rather
than in the mid-ascending aorta) is important (Figure
7), despite the higher and more turbulent forward velo-
cities encountered here, as underestimation of the regur-
gitation can occur otherwise [18]. This is due to a
number of factors, including movement of the valve
towards the LV apex during systole which allows blood
to flow into the gap between the imaging plane and the
valve. This blood may return to the ventricle during dia-
stole and not flow through the imaging plane, thus
being lost to measurement (Figure 8). This tendency is
exacerbated by several factors: aortic distension during
systole, a dilated aortic root (resulting in greater volume
between the imaging plane and the valve), and vigorous
longitudinal contraction of the LV (common in signifi-
cant AR). Placing the plane closer to the valve mini-
mises these errors, though avoiding the very highest
turbulence at the valve tips themselves is wise. An ideal
flow sequence would incorporate slice tracking to mini-
mise these errors, which tracks the aortic valve and
moves the imaging slice accordingly, but this involves
complex software programming and has only been per-
formed at a single centre so far [41].
The accuracy of aortic regurgitation quantification
using CMR through-plane velocity mapping is excellent
when compared to in-vitro studies [42] or in-vivo CMR
measurement using the difference between ventricular
volumes [20], and it correlates well with angiographic or
echocardiographic grades of severity [18,20,40]. As it
remains the only technique capable of true in-vivo
quantification of aortic regurgitation (without calcula-
tion), there is no ‘Gold standard’ for comparison of
accuracy. Reproducibility is also good, both for inter-
study and intra/inter observer comparisons [39,40]. The
technique is however subject to the same potential
Figure 6 Through-plane SSFP image in systole through the valve tips in a patient with aortic stenosis. The tips are outlined by dark (low
signal), partly due to signal loss from shear. The orifice area can in this case be measured directly by planimetry, but this should not be
attempted if the outlines are unclear on the available cine images.
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(under ‘flow and velocity quantification’), and care is
required to ensure good accuracy of the measurements.
In particular, non-breath-hold flow sequences are
recommended for their lower background flow offset
errors. Quantifying AR with CMR has recently shown a
good ability to predict symptom development and the
need for valve replacement surgery in the near future
[43], with a regurgitant fraction > 33% providing the
optimal threshold for identifying patients likely to
require surgery within a few years. Given the difficulty
in timing valve replacement surgery in patients with
severe AR [44], this may become a valuable tool in clini-
cal management, with the potential to identify suitable
patients for early surgery. The potential improvement in
outcome requires confirmation in a clinical trial
however.
AR quantification can also be achieved by a compari-
son of the differences in LV and RV stroke volume from
cine imaging alone [45], but this is less direct and relies
on the lack of any other valve regurgitation or shunt. It
also assumes accurate contour placement for volumetric
assessment, and inaccuracies in measuring any of the
four sets of contours (LV and RV in both diastole and
systole) can result in significant errors. Careful contour
placement is therefore required for this technique, parti-
cularly for the difficult RV contours. It is however a use-
ful technique when flow quantification cannot be
performed, or as an internal validation of the flow tech-
nique. An approximate assessment of the severity of
aortic regurgitation can also be obtained by visualisation
of the signal void of the regurgitant jet on cine imaging.
A narrow jet width at the origin suggests lower degrees
o fr e g u r g i t a t i o n ,w h i l eaw i d ej e t ,p a r t i c u l a r l yw i t ha
core of high signal from laminar flow, suggests more
severe regurgitation. This method is subject to many
potential errors however (indicated earlier), and is not
recommended for accurate evaluation.
Figure 7 LVOT view in diastole showing turbulent jet of aortic regurgitation (arrow) and position for through-plane velocity mapping
image (dashed lines) to quantify aortic flow.
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assessment of the impact of AR, and the high reproduci-
bility is particularly useful for serial assessment, which is
important for the management of a condition that has a
long asymptomatic phase. CMR-derived LV end-diasto-
lic volumes have also shown some ability to predict the
onset of symptoms or other indications for valve surgery
[43], and although less strong than quantifying the
regurgitation itself, it can provide a useful adjunct in
predicting outcome. CMR can also provide a detailed
assessment of aortic root anatomy, which can assist in
identifying the cause of the regurgitation, and/or
whether the root needs replacing at the time of valve
replacement surgery.
Taken together, the many CMR techniques useful in
AR, including regurgitation quantification, LV volu-
metric assessment and aortic root anatomy, make CMR
the optimal tool for comprehensive assessment.
Mitral regurgitation
As for aortic regurgitation, the main advantages of
CMR in mitral regurgitation are in quantitative
assessment of both the regurgitation, and ventricular
volume and function. CMR can also assess leaflet mor-
phology and valve function, particularly utilising the
free choice of image planes to characterise the aetiol-
ogy of the regurgitation in this complex valve. CMR
has good agreement with trans-oesophageal echocar-
diography for assessing mitral valves for repair [46],
though the slice thickness can result in partial volume
errors more frequently than echocardiography, which
has a very narrow beam width. A good method is to
place multiple cine images perpendicular to the mitral
valve commissure, facilitating assessment of the indivi-
dual scallops/coaption, and can identify the site of
localised prolapse/regurgitation [47]. This technique
can be modified by placing three slices specifically
across the commissure, perpendicular to the edge of
the leaflet at each of the scallops (Figure 9). This
results in reduced partial volume effects in the A1/P1
and A3/P3 views particularly, while also being margin-
ally quicker. Despite these good techniques, transoeso-
phageal echocardiography is likely to remain the
optimal investigation for leaflet assessment, due to its
Figure 8 (taken from the Oxford Handbook of CMR, OUP) Mechanism for potential underestimation of aortic regurgitation.T h eg a p
between the valve and the image plane for flow mapping expands in systole from a combination of movement of the aortic valve towards the
apex and elastic expansion of the aortic sinuses and root. Blood entering this space in systole (grey stippled area) returns to the LV in diastole
(via a regurgitant valve) without passing through the image plane (dashed lines), and thus may not be measured.
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images. CMR could be used if trans-oesophageal echo-
cardiography wasn’t possible, if doubts remained after
the echocardiogram, or if other aspects required
assessment by CMR and all could be investigated by a
single CMR scan. CMR can also be valuable in asses-
sing the regurgitant orifice using thin (4-5 mm) slices
parallel to the mitral annulus, carefully placed through
the mitral tips in systole [48]. In some patients this
can provide direct visualisation and measurement (if
required) of the regurgitant orifice area (rather than
calculated area from echocardiography), but the com-
plex shape and motion of the valve mean this is not
feasible in all patients.
Quantification of mitral regurgitation is usually per-
formed indirectly, mostly by subtracting aortic systolic
flow (measured by aortic flow mapping described above)
from LV stroke volume [29]. This relies on a combina-
tion of two different MR techniques and increases the
potential for measurement error, so care is required
with the flow sequence and LV contours, as previously
highlighted. Mitral regurgitation can also be quantified
Figure 9 Imaging the mitral valve segments - a modified approach adapted from reference 47. A basal short axis slice through the mitral
commissure is used (top left) to orientate the subsequent image slices for each of the segments. The left atrial appendage is identified by the
asterisk (*). Cine sequences are then acquired perpendicular to the mitral commissure for each of the 3 scallops (parallel dashed lines). Systolic
frames from the resulting images are shown here (top right and bottom images). In this patient, there is isolated prolapse of the posterior leaflet
P2 segment (bottom right, black arrow), but other segments have normal coaption (top right and bottom left).
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volumes, as for aortic regurgitation, but the same limita-
tions apply, including the assumption of a single valve
lesion and the need for accurate contour placement.
The quantification of mitral regurgitation correlates well
with echocardiographic and angiographic assessmentand
has good reproducibility [49-51]. The potential clinical
utility of quantification is shown by the good ability to
predict the future need for surgery in asymptomatic
patients [52], similarly to aortic regurgitation, with a
regurgitant fraction of 40% providing the optimal
threshold for MR. Although this prognostic ability was
not quite as strong as for aortic regurgitation, it is sig-
nificantly greater than echocardiographic semi-quantita-
tion using the proximal isovolumetric surface area
(PISA) technique for estimating mitral regurgitant ori-
fice area [53]. Quantitative CMR measures may become
a valuable clinical tool to identify suitable patients for
early valve surgery, as for aortic regurgitation, though
again clinical trials are required to determine if this
potential for identifying patients for early surgery trans-
lates into improved clinical outcomes. Direct quantifica-
tion of the regurgitation using CMR is possible using
through-plane flow mapping on the atrial side of the
mitral valve [54] (Figure 10), but is difficult due to the
highly mobile valve and often eccentric, mobile jets of
regurgitation. Despite these difficulties, it has reasonable
agreement with indirect quantification and can provide
an alternative method. Atrial fibrillation is more com-
mon in patients with mitral regurgitation, and this can
reduce the accuracy of flow measurements [54], but is
improved if the heart rate variability is low [54].
Similarly to AR, an approximate assessment of the
severity of mitral regurgitation can be obtained by visua-
lisation of the signal void of the regurgitant jet on cine
imaging, with a narrow jet width suggestinglower
degrees of regurgitation and a wide jet (particularly with
a core of high signal) suggesting more severe regurgita-
tion. However, the same limitations apply, and this
method is only useful as a rough guide.
Mitral stenosis
Echocardiography, particularly trans-oesophageal echo-
cardiography, remains the first line technique for asses-
sing mitral stenosis due to its excellent visualisation of
the mitral leaflets. CMR can be helpful in selected cases
however, with good visualisation of the restricted mitral
leaflets, particularly on the LVOT view. Direct measure-
ment of the orifice area can be performed in much the
same way as for aortic stenosis, by placing an imaging
plane at the mitral valve tips during diastole (Figure 11).
The technique has good agreement with echocardiogra-
phy [55], but care needs to be taken in positioning the
plane at the tips in order to obtain an accurate valve
area, and multiple parallel thin slices may be helpful.
Diastolic flow and velocity can also be measured in this
image plane, and pressure half time calculated as for
echocardiography [56], though the frequency of atrial
fibrillation in severe mitral stenosis reduces the accuracy
of the flow measurements [54].
Right-sided valve lesions
The pulmonary valve
The pulmonary valve and right ventricular outflow tract
can be difficult to assess with echo, due to several fac-
tors. The location of the valve and outflow tract imme-
diately behind the sternum makes it difficult to position
the echo probe adequately to visualise the area. The
qualitative echo assessment of pulmonary regurgitation
is also less robust than for aortic regurgitation, and
grading regurgitation severity can be difficult. Thirdly,
the right ventricle can be difficult to assess, particularly
for volumetric assessment, due to its unusual shape.
CMR is therefore particularly valuable for assessing the
pulmonary valve, with its combination of free choice of
imaging planes, velocity & flow assessment, and accurate
assessment of RV anatomy and volumes. Despite the
very thin nature of the normal pulmonary valve, making
it difficult to visualise with CMR, these other advantages
are considerable, and CMR should be considered the
‘Gold standard’ for assessment of the pulmonary valve
and RV outflow tract.
Pulmonary stenosis
The excellent visualisation of the RV outflow tract
with CMR facilitates easy identification of the site and
severity of pulmonary stenosis. An RV outflow tract
view (usually an oblique sagittal plane), including the
proximal pulmonary trunk and a very fore-shortened
right ventricle, is ideal (Figure 12). Care is required
however to ensure the outflow tract remains in the
plane during the whole cardiac cycle, due to the sig-
nificant long axis motion of the RV. Acquiring a cine
image in a more horizontal plane through the RVOT,
perpendicular to the first (imperfect) RVOT view, can
help plan a subsequent improved RVOT view
throughout the whole cardiac cycle. A qualitative
assessment of severity can be made from the cine
views, by visualising the valve motion and stenotic jet.
Quantitative assessment is similar to that for aortic
stenosis, and direct planimetry of the valve orifice
f r o mac i n ei m a g et h r o u g ht h ev a l v et i p si st h ep r e -
ferred method for assessing severity. Peak velocity can
also be measured, as for aortic stenosis, though has
similar limitations, particularly for high velocity jets.
Identifying sub-valvar and supra-valvar stenosis is
straightforward with the long axis views through the
outflow tract, and in-plane velocity mapping in these
planes can be helpful in identifying the point of
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mass and function can be assessed to determine the
effect on the RV, and any concomitant pulmonary
trunk or branch artery stenosis can be identified with
either a thin-slice SSFP anatomical stack or MR
angiography of the pulmonary arteries.
Pulmonary regurgitation
Trivial or mild pulmonary regurgitation (PR) is common
in normal subjects (~30% of the population [57]), but
rarely of importance. More significant degrees of regur-
gitation are usually related to congenital heart disease,
with the largest group being patients with repaired tet-
ralogy of Fallot, who commonly have significant residual
PR [58-60]. CMR has revolutionised the investigation
and follow up of such patients, as it accurately assesses
two important aspects - the quantity of regurgitation
and RV volumes/function [61], and is the method of
choice for examining PR in this patient group.
Figure 10 Location for direct assessment of mitral regurgitation flow using through-plane velocity mapping. Slice position indicated by
dashed lines in LVOT view (top) and VLA view (bottom), perpendicular to the regurgitant jet (arrowed).
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tation. RV outflow tract cine images can give an idea of
anatomy, but as pulmonary pressures are lower than
systemic, the degree of turbulence from PR is often
l o w e ra n dm a yb ep o o r l yv i s u a l i s e do nc i n ei m a g e s ,
especially SSFP (Figure 13). In-plane phase contrast
velocity mapping sequences are better for visualising the
regurgitant jet (Figure 13). Accurate quantification can
be performed using through-plane velocity mapping,
with the image slice placed just above the pulmonary
valve (Figure 13). This method compares well to quanti-
fication by comparing ventricular stroke volumes [59],
correlates with echocardiographic parameters [62], and a
regurgitant fraction ≥40% has been considered severe
Figure 11 Assessing mitral stenosis by direct planimetry of the mitral tips. Top: diastolic frame from an LVOT view demonstrating slice
position for subsequent imaging (dashed line). Bottom: resulting modified short axis view through the mitral tips in diastole, showing the easily
visualized mitral orifice (arrow).
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to the problems of background flow offset errors how-
ever [25], and attempts should be made to minimise
these wherever possible. This includes choosing image
planes close to the transverse view (where appropriate),
non-breath-hold flow sequences, and background cor-
rection where possible. Accurate measurement of RV
volumes and function are particularly important, and
can help guide the timing of valve replacement [60,63].
Excess RV volume loading can also be inferred from
abnormal diastolic motion of the ventricular septum
towards the LV in diastole, best appreciated on short
axis ventricular cine images. The optimal CMR thresh-
olds for recommending surgery are uncertain, but in
adults with severe chronic PR following tetralogy of Fal-
lot repair, a recent retrospective study noted that an RV
end-diastolic volume index < 160 mL/m
2 resulted in a
greater chance of normalisation of RV dimensions after
pulmonic valve replacement [64]. Studies to assess the
optimal clinical use of CMR quantification and the opti-
mal thresholds for intervention are on-going, and may
ultimately reduce the long term RV dysfunction that can
result [60,65].
Percutaneous pulmonary valve replacement
Percutaneous pulmonary valve replacement using a
stent-valve is increasing in popularity, and accurate siz-
ing and anatomy of the pulmonary outflow tract is
important for determining suitable patients [66,67].
CMR provides the required detail, in addition to accu-
rate assessment of the valve lesion itself, and is invalu-
able in the assessment of patients for this procedure
[66]. Despite the metal content of the stents, follow-up
flow imaging can still occur above & below the stent,
and some newer nitinol stents can allow flow assess-
ment within the stent [68], though the accuracy is more
uncertain.
Figure 12 Right ventricular outflow tract view showing fore-shortened right ventricle (RV) and a pulmonary valve with moderate-
severe stenosis. The high velocity jet of the stenosis can be seen (arrowed). PA = main pulmonary artery.
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Tricuspid regurgitation
CMR offers similar capabilities for the assessment of tri-
cuspid regurgitation (TR) as for mitral regurgitation.
SSFP cine sequences are used to visualise the anatomy
and function of the leaflets. The horizontal long axis
view provides a good overview, but multiple contiguous
transverse images through the valve can often provide
additional useful information, particularly for abnormal
leaflet morphology such as in Ebstein’s anomaly. Visua-
lising the jet is difficult on SSFP sequences due to the
lower shear and turbulence, but qualitative assessment
of the TR jet can be achieved with in-plane velocity
mapping in a long axis RV view (Figure 14). Wider jets
(especially > 7 mm at the vena contracta) suggest more
severe tricuspid regurgitation. The regurgitant orifice
can sometimes be assessed directly, in a similar fashion
to mitral regurgitation, with a cine image through the
leaflet tips in systole (Figure 15). Through-plane velocity
mapping in this plane can also aid in visualising the size
of the regurgitant orifice by visualising the flow jet in
cross section. This allows assessment of the regurgitant
orifice area, though thresholds for guiding severity grad-
ing are not yet available. The ‘diameter’ of the
regurgitant orifice can be assessed (as per echo proto-
cols) but this is only an approximate guide as the regur-
gitant orifice is often non-circular. Again, this may be
inferior to quantification of the regurgitation.
Quantification can be achieved using pulmonary flow
measurement (as acquired for pulmonary regurgitation),
combined with RV stroke volume to calculate the regur-
gitant volume (= RV stroke volume - pulmonary for-
ward flow) and the regurgitant fraction (TR/RV stroke
volumes × 100%) [69], in much the same way as for
mitral regurgitation. The same limitations apply, as
combination MR techniques are used to calculate regur-
gitation quantity, and care is required with both the
flow sequence and RV contouring, which can be espe-
cially difficult. Accuracy of the flow sequence in particu-
lar is also reduced in very irregular rhythms - not
uncommon with TR. Quantifying the TR can also be
assessed using the difference in ventricular stroke
volumes if only a single valve leak is present [70], with
the same issues about the need for accurate contour pla-
cement as in MR.
Patients with abnormal placement of the tricuspid
valve (Ebstein’s anomaly) often present a challenge for
assessing true RV volumes & function, as well as the
Figure 13 Left: RV outflow tract view in diastole in a patient with repaired Fallot’s tetralogy and severe pulmonary regurgitation.
There is almost no turbulence, due to the wide jet with mostly laminar flow. The flow can be visualized with in-plane flow imaging (right),
where the wide regurgitant jet is seen in black (arrowed). The dashed lines on the cine image indicate the slice location for through-plane
velocity mapping.
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Page 16 of 23extent of tricuspid regurgitation, due to the difficulty of
identifying the true ventricle on short axis images. Good
post-processing software which allows identification of
the valve position in the long axis views can help con-
siderably with this, and CMR can produce accurate
assessments which aid management [71,72].
Tricuspid stenosis
Although extremely rare, and not routinely assessed
with CMR, this valve lesion can be examined when
required. Valve area can be measured by placement of
an image slice through the valve tips in diastole, as for
mitral stenosis, and forward velocity through the valve
Figure 14 Severe tricuspid regurgitation seen in the HLA view. In the SSFP cine (top), there is little regurgitation seen due to the minimal
turbulence from the jet. Bottom: in-plane velocity mapping sequence in the same position demonstrating the wide jet of torrential regurgitation
(arrowed).
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useful.
Multiple valve lesions
CMR can be used to assess patients with multiple valve
lesions, obtaining a detailed assessment of the severity
of each component whether these occur in the same
valve (i.e. mixed valve disease) or in different valves. As
an extreme example, a patient with both mixed aortic
and mixed mitral valve disease could have the opening
area of each valve measured by direct planimetry with
cine imaging to assess stenosis, the aortic regurgitation
quantified from the diastolic (regurgitant) flow above
the aortic valve and the mitral regurgitation quantified
by subtracting the systolic (forward) flow above the aor-
tic valve from the LV stroke volume. LV volumes and
function would also be assessed. In this way, a compre-
hensive assessment can be undertaken.
Prosthetic valves
Despite perceived contraindications, all prosthetic heart
valves are safe in the MR scanner at 1.5 T and the vast
majority are safe at 3T (not all have been tested)
[73,74]. Even for mildly ferromagnetic valves, the forces
exerted on the valve by the scanner are negligible when
compared to those occurring with each heart-beat. Most
valves produce an artefact, though the size is variable -
bi-leaflet tilting discs have a smaller artefact than older
ball & cage valves, though some bioprosthetic valves
have significant amounts of metal in the frame which
can produce a larger artefact. Prosthetic heart valves can
even be assessed using CMR, including flow patterns
and anatomy around the valve [75,76] (Figure 16). Some
bioprosthetic valves can have the opening of the leaflets
assessed by SSFP cine imaging with good accuracy [77],
though not all are amenable to this. The leaflet motion
of mechanical valves is not usually amenable to CMR
visualisation due to the considerable artefact and the
lack of signal from the valve leaflets. However, reason-
able visualisation of leaflet motion can sometimes be
obtained in some tilting disc valves with careful image
positioning perpendicular to the leaflet hinge line. The
motion of the discs may be seen from the moving signal
void, but this technique is far less precise than x-ray
fluoroscopy. The flow pattern of prosthetic valves can
however usually be assessed using through-plane velo-
city mapping, with the image slice placed downstream
of the signal void artefact. Bioprosthetic valves have a
Figure 15 Tricuspid regurgitation; modified short axis cine view in systole, positioned through the tricuspid valve tips.T h el a r g e
regurgitant orifice is easily visualized in this case (arrowed). In some cases, through-plane velocity mapping may give clearer delineation of flow
through the orifice.
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leaflet tilting disc valves have a characteristic flow pat-
tern (Figure 17), reminiscent of the profile of a Star
Wars™ TIE (Twin Ion Engine) fighter.
Prosthetic valve dysfunction can also be assessed. If
one leaflet of a bi-leaflet tilting disc valve fails to open
properly, one side of the flow pattern will be missing
and this may be identified with CMR. Paraprosthetic
leaks can be visualised with careful image positioning,
and can even be quantified with careful through-plane
velocity mapping. While less conventional than other
imaging modalities, these techniques can be extremely
helpful in selected patients. CMR is also particularly
good for assessing the anatomy of the aortic root
around the valve, including grafts and valve-graft con-
duits, and any dissection or false aneurysm that may be
present.
Limitations
Arrhythmias
Irregular cardiac rhythms degrade image quality, which
affects the assessment of ventricular function, though
the effect on this is usually small. The accuracy of flow
measurement can also be reduced [54] as flow
sequences are acquired over several cardiac cycles
(typically 10-12), with data acquired in a complex
Figure 16 Prosthetic valves with CMR. Top: Carbomedics bioprosthetic valve in the aortic position in systole (left) and diastole (right). Bottom:
ATS bi-leaflet tilting disc valves in both aortic and mitral positions (arrowed).
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Page 19 of 23manner, and reconstructed based on the assumption of
a regular rhythm. In subjects with an irregular rhythm,
the complexity of the data acquisition means that
although acquired over several cardiac cycles, flow is
not averaged over these, as might be expected. Where
the beat-to-beat variability is small (e.g. atrial fibrilla-
tion with a controlled rate), these errors are usually
not clinically significant [54]. Very irregular rhythms
however (e.g. uncontrolled atrial fibrillation, multiple
ventricular ectopics) can present a challenge, particu-
larly to acquiring accurate flow data. Intelligent plan-
ning of the timing of data acquisition to the ECG can
offset some of the problems, but some patients still
present a challenge and caution should be exercised in
interpreting the flow data in these. Cine imaging may
be more reliable as it is more amenable to intelligent
ECG gating and is less affected by arrhythmias, parti-
cularly during systole. Ventricular volumes vary with
differing heart rates due to differential filling, and
these physiological changes do of course still occur,
a n dr e s u l ti ns l i g h tb l u r r i n go ft h em y o c a r d i a lb o r d e r s .
The result is an approximate averaging of the volumes
over the several cardiac cycles of image acquisition,
which is usually acceptable. Flow imaging may be
improved with the newer ECG gating techniques for
arrhythmias, which typically omit cardiac cycles out-
side a defined range.
Haemodynamic assessment
One limitation that remains with CMR is the inability to
measure directly the pressure inside a vessel or cardiac
chamber - a limitation of all imaging modalities. As for
echocardiography, CMR can measure velocity across a
stenosis and derive a pressure drop from this, but abso-
lute pressure quantification remains elusive. Cardiac
catheterisation remains the most accurate method for
assessing this. One paper has identified how CMR may
indirectly indicate pressure, by examining the complex
flow patterns in the pulmonary artery using 3-dimen-
sional flow imaging [78]. The paper suggested that pul-
monary pressure (measured invasively) was strongly
linked with the type of flow pattern in the main pul-
monary artery. The data requires further validation but
indicates the novel approaches to assessment that CMR
may bring in the future.
Conclusions
CMR can provide a comprehensive assessment of valvu-
lar heart disease, including quantification of valve regur-
gitation and other flows, and accurate cardiac volumes
Figure 17 Through-plane velocity mapping above a prosthetic aortic valve (bi-leaflet tilting disc type). The characteristic flow pattern of
two crescents and a bridging ‘strut’ can be seen, reminiscent of a Star Wars™ TIE fighter viewed from the front.
Myerson Journal of Cardiovascular Magnetic Resonance 2012, 14:7
http://www.jcmr-online.com/content/14/1/7
Page 20 of 23and mass for assessing the effect on both ventricles.
Combined with the ability to image all areas of the
heart (including difficult areas such as the right ventricle
and pulmonary valve), it is an excellent adjunct to echo-
cardiography for investigating patients with valve dis-
ease. Further studies of clinical outcome, using
quantitative CMR data to guide management, are
needed to enhance it as a strong tool for guiding clinical
practice.
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